![](/img/cover-not-exists.png)
A strategy implementing initial therapy with a fixed- dose combination tablet of sitagliptin and metformin in patients with type 2 diabetes provides superior glycaemic control compared with a strategy using initial metformin monotherapy over 44 weeks
Olansky, L., Reasner, C.A., Seck, T., Williams-Herman, D., Luo, E., Chen, M., Reigle, L., Ling, Y., Taggart, W., Kaufman, K., Goldstein, B.J.Volume:
33
Year:
2009
Language:
english
Journal:
Canadian Journal of Diabetes
DOI:
10.1016/S1499-2671(09)33070-1
File:
PDF, 450 KB
english, 2009